Dana Pizzuti Plans Sale of 10,000 CRNX Shares

CRNX insider Dana Pizzuti has filed a Form 144 to sell 10,000 shares of common stock.

Rhea-AI Filing Summary

CRNX insider Dana Pizzuti has filed a Form 144 to sell 10,000 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on NASDAQ around February 2, 2026, has an aggregate market value of 499,400.00, with 94,891,840 shares outstanding.

The 10,000 shares were acquired the same day via a cash exercise of stock options. Over the prior three months, Pizzuti sold a total of 15,000 common shares in three 10b5-1 plan transactions, with gross proceeds of 232,590.50, 225,091.50, and 213,300.50.

FAQ

What does the CRNX Form 144 filing by Dana Pizzuti disclose?

The filing discloses an intended sale of 10,000 CRNX common shares. Dana Pizzuti plans to sell these shares on NASDAQ through Morgan Stanley Smith Barney LLC, with an indicated aggregate market value of 499,400.00 and 94,891,840 shares of CRNX common stock outstanding.

How many CRNX shares is Dana Pizzuti planning to sell under Rule 144?

Dana Pizzuti plans to sell 10,000 CRNX common shares under Rule 144. The shares are to be sold on or about February 2, 2026 on NASDAQ, with an aggregate market value of approximately 499,400.00 based on the market price referenced in the Form 144 notice.

How were the 10,000 CRNX shares in the Form 144 acquired?

The 10,000 CRNX shares were acquired by exercising stock options. The Form 144 states the shares were obtained on February 2, 2026 through an option exercise from the issuer, with payment made in cash on the same date for the 10,000 acquired shares.

What recent CRNX stock sales has Dana Pizzuti already completed?

Pizzuti sold 15,000 CRNX shares over the prior three months. The Form 144 lists three 10b5-1 sales of 5,000 common shares each on November 3, 2025, December 1, 2025, and January 2, 2026, with gross proceeds of 213,300.50, 225,091.50, and 232,590.50.

Which broker will handle Dana Pizzuti’s planned sale of CRNX shares?

The planned CRNX share sale will be handled by Morgan Stanley Smith Barney LLC. The Form 144 specifies Morgan Stanley Smith Barney LLC Executive Financial Services at One New York Plaza, New York, NY 10004 as the broker for the 10,000-share NASDAQ transaction.

How many CRNX shares are outstanding according to this Form 144?

The Form 144 lists 94,891,840 CRNX common shares outstanding. This figure provides context for the 10,000-share intended sale by Dana Pizzuti and is reported in the securities information section alongside the planned aggregate market value and trading venue details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001948238
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CRINETICS PHARMACEUTICALS INC
SEC File Number	001-38583
Address of Issuer	6055 Lusk Boulevard San Diego CALIFORNIA 92121
Phone	8584506464
Name of Person for Whose Account the Securities are To Be Sold	DANA PIZZUTI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	499400.00	94891840	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Exercise of Stock Options	Issuer			10000	02/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	01/02/2026	5000	232590.50
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	12/01/2025	5000	225091.50
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	11/03/2025	5000	213300.50

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dana Pizzuti
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)